abstract |
The present invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting HSD17B13, as well as methods of inhibiting the expression of HSD17B13, and subjects that benefit from reduction of the expression of HSD17B13 using such dsRNA compositions, such as HSD17B13-related diseases. , A disorder, or a method of treating a subject suffering from a condition. |